9
H index
6
i10 index
235
Citations
Paul Vincent Grootendorst : Citation Profile
University of Toronto (10% share) | RESEARCH PRODUCTION: 16 Articles 35 Papers 2 Chapters RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
29 years (1993 - 2022). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Paul Vincent Grootendorst. | Is cited by:
| Cites to:
|
Main data
Where Paul Vincent Grootendorst has published?
| Journals with more than one article published | # docs |
|---|---|
| Health Policy | 4 |
| Health Economics | 3 |
| Journal of Health Economics | 2 |
Recent works citing Paul Vincent Grootendorst (2025 and 2024)
| Year | Title of citing document |
|---|---|
| 2024 | The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis. (2024). Hollis, Aidan ; Zhang, Wei ; Grootendorst, Paul ; Guh, Daphne P ; Anis, Aslam H. In: Health Policy. RePEc:eee:hepoli:v:144:y:2024:i:c:s0168851024000745. Full description at Econpapers || Download paper |
| 2024 | Harm reduction for addictive consumption: When does it improve health and when does it backfire?. (2024). Dragone, Davide ; Cawley, John. In: Journal of Health Economics. RePEc:eee:jhecon:v:98:y:2024:i:c:s0167629624000766. Full description at Econpapers || Download paper |
| 2024 | Estimating price elasticities of demand for pain relief drugs: evidence from Medicare Part D. (2024). Soni, Aparna. In: International Journal of Health Economics and Management. RePEc:kap:ijhcfe:v:24:y:2024:i:4:d:10.1007_s10754-024-09382-3. Full description at Econpapers || Download paper |
| 2025 | Target-aware 3D molecular generation based on guided equivariant diffusion. (2025). Zhang, Kai ; Li, Honglin ; Hu, Qiaoyu ; Sun, Changzhi ; He, Huan ; Xu, Jiazheng ; Liu, Danlin ; Shi, Sumeng. In: Nature Communications. RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-63245-0. Full description at Econpapers || Download paper |
| 2025 | Substitution and Complementarity in the Consumption of Alcohol, Cannabis, and Opium. (2025). Doshi, Gaurav ; Chandra, Siddharth. In: Health Economics. RePEc:wly:hlthec:v:34:y:2025:i:5:p:827-854. Full description at Econpapers || Download paper |
Works by Paul Vincent Grootendorst:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2000 | The Effects of Drug Subsidies on Out-of-Poket Prescription Drug Expenditures by seniors: regional Evidence from Canada. In: CEPR Discussion Papers. [Full Text][Citation analysis] | paper | 14 |
| 2002 | The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.(2002) In: Journal of Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 14 | article | |
| 2000 | The Effects of Drug Subsidies on Out-of Pocket Prescription Drug Expenditures by Seniors: Regional Evidence from Canada.(2000) In: Quantitative Studies in Economics and Population Research Reports. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 14 | paper | |
| 2000 | The Effects of Drug Subsidies on Out-of Pocket Prescription Drug Expenditures by Seniors: Regional Evidence from Canada.(2000) In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 14 | paper | |
| 2015 | Intellectual Property Protection And Drug Plan Coverage: Evidence From Ontario In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 2020 | An Empirical Examination of the Patented Medicine Prices Review Board Price Control Amendments on Drug Launches in Canada In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2005 | Distributional effects of `general population prescription drug programs in Canada In: Canadian Journal of Economics. [Full Text][Citation analysis] | article | 12 |
| 2005 | Distributional effects of ‘general population’ prescription drug programs in Canada.(2005) In: Canadian Journal of Economics/Revue canadienne d'économique. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 12 | article | |
| 2010 | New Approaches to Rewarding Pharmaceutical Innovation In: Levine's Bibliography. [Full Text][Citation analysis] | paper | 3 |
| 2001 | An Empirical Analysis of Milk Addiction In: Working Papers. [Citation analysis] | paper | 56 |
| 2004 | An empirical analysis of milk addiction.(2004) In: Journal of Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 56 | article | |
| 2005 | National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirbys Recommendations? In: Canadian Public Policy. [Full Text][Citation analysis] | article | 0 |
| 2003 | National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirbys Recommendations?.(2003) In: Quantitative Studies in Economics and Population Research Reports. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
| 2003 | National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirbys Recommendations?.(2003) In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
| 2011 | The cost of drug development: A systematic review In: Health Policy. [Full Text][Citation analysis] | article | 23 |
| 2022 | The effect of patented drug price on the share of new medicines across OECD countries In: Health Policy. [Full Text][Citation analysis] | article | 2 |
| 2001 | On the evaluation of drug benefits policy changes with longitudinal claims data: the policy makers versus the clinicians perspective In: Health Policy. [Full Text][Citation analysis] | article | 2 |
| 2007 | The effects of coxib formulary restrictions on analgesic use and cost: Regional evidence from Canada In: Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2012 | Prescription Drug Insurance and Reimbursement In: Chapters. [Full Text][Citation analysis] | chapter | 1 |
| 2006 | Prescription Drug Insurance and Reimbursement.(2006) In: Chapters. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | chapter | |
| 1993 | Results of an Investigation into the Integrity of the Ontario Health Survey In: Centre for Health Economics and Policy Analysis Working Paper Series. [Full Text][Citation analysis] | paper | 0 |
| 1994 | Does It Matter Whom and How You Ask? Inter and Intra-rater Agreement in the Ontario Health Survey In: Centre for Health Economics and Policy Analysis Working Paper Series. [Full Text][Citation analysis] | paper | 9 |
| 1995 | On Becoming 65 in Ontario: Effects of Provincial Drug Plan Eligibility on Utilization of Prescription Medicines In: Centre for Health Economics and Policy Analysis Working Paper Series. [Full Text][Citation analysis] | paper | 1 |
| 1996 | Financial Incentives to Dispense Low-Cost Drugs: A Case Study of British Columbia Pharmacare In: Centre for Health Economics and Policy Analysis Working Paper Series. [Full Text][Citation analysis] | paper | 2 |
| 1998 | Variance in Pharmacare Coverage Across Canada In: Centre for Health Economics and Policy Analysis Working Paper Series. [Full Text][Citation analysis] | paper | 1 |
| 1999 | Health Utilities Index Mark 3: Evidence of Construct Validity for Stroke and Arthritis in a Population Health Survey In: Centre for Health Economics and Policy Analysis Working Paper Series. [Full Text][Citation analysis] | paper | 9 |
| 1999 | Beneficiary Cost Sharing Under Canadian Provincial Prescription Drug Benefit Programs: History and Assessment In: Centre for Health Economics and Policy Analysis Working Paper Series. [Full Text][Citation analysis] | paper | 6 |
| 2001 | International Experience With Pharmaceutical Policy: Common Challenges and Lessons for Canada In: Centre for Health Economics and Policy Analysis Working Paper Series. [Full Text][Citation analysis] | paper | 2 |
| 2003 | Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs In: IZA Discussion Papers. [Full Text][Citation analysis] | paper | 1 |
| 2002 | Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs.(2002) In: Quantitative Studies in Economics and Population Research Reports. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | paper | |
| 2002 | Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs.(2002) In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | paper | |
| 1999 | Evidence of Construct Validity for Stoke and Arthritis in a Population Health Survey In: Department of Economics Working Papers. [Full Text][Citation analysis] | paper | 2 |
| 2002 | The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume I: Summary In: Quantitative Studies in Economics and Population Research Reports. [Full Text][Citation analysis] | paper | 1 |
| 2002 | The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume I: Summary.(2002) In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | paper | |
| 2002 | The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume II: Technical Report In: Quantitative Studies in Economics and Population Research Reports. [Full Text][Citation analysis] | paper | 0 |
| 2002 | The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume II: Technical Report.(2002) In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
| 2002 | Do Drug Plans Matter? Effects of Drug Plan Eligibility on Drug Use Among the Elderly, Social Assistance Recipients and the General Population In: Quantitative Studies in Economics and Population Research Reports. [Full Text][Citation analysis] | paper | 7 |
| 2002 | Do Drug Plans Matter? Effects of Drug Plan Eligibility on Drug Use Among the Elderly, Social Assistance Recipients and the General Population.(2002) In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 7 | paper | |
| 2004 | The Impact of Differential Cost Sharing of Non-Steroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] | paper | 5 |
| 2007 | Effects of Authorized-Generics on Canadian Drug Prices In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] | paper | 1 |
| 2007 | A review of instrumental variables estimation in the applied health sciences In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] | paper | 6 |
| 2007 | The life expectancy gains from pharmaceutical drugs: a critical appraisal of the literature In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] | paper | 2 |
| 2009 | How should we support pharmaceutical innovation? In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] | paper | 3 |
| 2009 | Patents, Public-Private Partnerships or Prizes – How should we support pharmaceutical innovation? In: Social and Economic Dimensions of an Aging Population Research Papers. [Full Text][Citation analysis] | paper | 0 |
| 2011 | Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey In: Monash Economics Working Papers. [Full Text][Citation analysis] | paper | 3 |
| 2017 | Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 0 |
| 2014 | Do downturns cause desperation? The effect of economic conditions on suicide rates in Canada In: Applied Economics. [Full Text][Citation analysis] | article | 4 |
| 2015 | Newtons First Law as Applied to Pharmacies: Why Entry Order Matters for Generics In: International Journal of the Economics of Business. [Full Text][Citation analysis] | article | 2 |
| 2005 | Estimating the price elasticity of expenditure for prescription drugs in the presence of non‐linear price schedules: an illustration from Quebec, Canada In: Health Economics. [Full Text][Citation analysis] | article | 32 |
| 2006 | A re‐examination of the impact of reference pricing on anti‐hypertensive drug plan expenditures in British Columbia In: Health Economics. [Full Text][Citation analysis] | article | 9 |
| 1997 | Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator In: Health Economics. [Full Text][Citation analysis] | article | 12 |
| 2017 | Does rising income inequality affect mortality rates in advanced economies? In: Economics Discussion Papers. [Full Text][Citation analysis] | paper | 1 |
| 2017 | Does rising income inequality affect mortality rates in advanced economies?.(2017) In: Economics - The Open-Access, Open-Assessment E-Journal (2007-2020). [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | article |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated December, 22 2025. Contact: CitEc Team